Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier

被引:48
|
作者
Miecz, Dorota [1 ]
Januszewicz, Elzbieta [1 ]
Czeredys, Magdalena [1 ]
Hinton, Barry T. [2 ]
Berezowski, Vincent [3 ]
Cecchelli, Romeo [3 ]
Nalecz, Katarzyna A. [1 ]
机构
[1] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland
[2] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA
[3] Univ Artois EA 2465, IMPRT IFR 114, Fac Sci Jean Perrin, Jean Perrin, Lens, France
关键词
astrocytes; blood-brain barrier; carnitine; organic cation/carnitine transporter 2;
D O I
10.1111/j.1471-4159.2007.05024.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carnitine beta-hydroxy-gamma-(trimethylammonio)butyrate - a compound necessary in the peripheral tissues for a transfer of fatty acids for their oxidation within the cell, accumulates in the brain despite low beta-oxidation in this organ. In order to enter the brain, carnitine has to cross the blood-brain barrier formed by capillary endothelial cells which are in close interaction with astrocytes. Previous studies, demonstrating expression of mRNA coding two carnitine transporters - organic cation/carnitine transporter 2 (OCTN2) and B-0,B-+ in endothelial cells, did not give any information on carnitine transporters polarity in endothelium. Therefore more detailed experiments were performed on expression and localization of a high affinity carnitine transporter OCTN2 in an in vitro model of the blood-brain barrier by real-time PCR, western blot analysis, and immunocytochemistry. The amount of mRNA was comparable in endothelial cells and kidney, when referred to house-keeping genes, it was, however, significantly lower in astrocytes. Polarity of OCTN2 localization was further studied in an in vitro model of the blood-brain barrier with use of anti-OCTN2 antibodies. Z-axis analysis of the confocal microscope pictures of endothelial cells, with anti-P-glycoprotein antibodies as the marker of apical membrane, showed OCTN2 localization at the basolateral membrane and in the cytoplasmic region in the vicinity of nuclei. Localization of OCTN2 suggest that carnitine can be also transported from the brain, playing an important role in removal of certain acyl esters.
引用
收藏
页码:113 / 123
页数:11
相关论文
共 50 条
  • [41] Involvement of Carnitine/organic Cation Transporter OCTN2 (SLC22A5) in Distribution of its Substrate Carnitine to the Heart
    Iwata, Daisuke
    Kato, Yukio
    Wakayama, Tomohiko
    Sai, Yoshimichi
    Kubo, Yoshiyuki
    Iseki, Shoichi
    Tsuji, Akira
    DRUG METABOLISM AND PHARMACOKINETICS, 2008, 23 (03) : 207 - 215
  • [42] Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2)
    Szabo, Kitti
    Nagy, Zoltan
    Juhasz, Viktoria
    Zolnerciks, Joseph K.
    Csorba, Attila
    Timar, Zoltan
    Molnar, Eva
    Padar, Petra
    Johnson, William
    Beery, Erzsebet
    Krajcsi, Peter
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (03) : 165 - 171
  • [43] Interaction and functional regulation of carnitine/organic cation transporter OCTN2 by PDZ protein PDZK1
    Kato, Y
    Chizuru, W
    Yoshida, K
    Hirata, T
    Kubo, Y
    Tsuji, A
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 71A - 71A
  • [44] Organic cation/carnitine transporter (OCTN2) interaction proteome in rat astrocytes: Role of phosphatase PP2A
    Nalecz, Katarzyna
    Juraszek, Barbara
    SPRINGERPLUS, 2015, 4
  • [45] Different Involvement of Promoter Methylation in the Expression of Organic Cation/Carnitine Transporter 2 (OCTN2) in Cancer Cell Lines
    Qu, Qiang
    Qu, Jian
    Zhan, Min
    Wu, Lan-Xiang
    Zhang, Yi-Wen
    Lou, Xiao-Ya
    Fu, Li-Juan
    Zhou, Hong-Hao
    PLOS ONE, 2013, 8 (10):
  • [46] Na+-dependent carnitine transport by organic cation transporter (OCTN2):: Its pharmacological and toxicological relevance
    Ohashi, R
    Tamai, I
    Yabuuchi, H
    Nezu, J
    Oku, A
    Sai, Y
    Shimane, M
    Tsuji, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 291 (02): : 778 - 784
  • [47] Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2
    Spiekerkoetter, U
    Huener, G
    Baykal, T
    Demirkol, M
    Duran, M
    Wanders, R
    Nezu, J
    Mayatepek, E
    JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (06) : 613 - 615
  • [48] Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa
    Kobayashi, Daisuke
    Tamai, Ikumi
    Sai, Yoshimichi
    Yoshida, Kazuhiro
    Wakayama, Tomohiko
    Kido, Yasuto
    Nezu, Jun-ichi
    Iseki, Shoichi
    Tsuji, Akira
    REPRODUCTION, 2007, 134 (05) : 651 - 658
  • [49] Carnitine/Organic Cation Transporter OCTN2 (Slc22a5) Is Responsible for Renal Secretion of Cephaloridine in Mice
    Kano, Takashi
    Kato, Yukio
    Ito, Kimihiro
    Ogihara, Takuo
    Kubo, Yoshiyuki
    Tsuji, Akira
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (05) : 1009 - 1016
  • [50] Promotor analysis of human carnitine transporter (OCTN2) gene
    Takikawa, O
    Yamato, A
    Moli, D
    Miwa, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 282P - 282P